Related Experiment Videos
Chronic cutaneous lupus flare induced by systemic 5-fluorouracil
The Journal of Dermatological Treatment
|February 10, 2006
Summary
5-Fluorouracil, a breast cancer drug, can trigger skin reactions. This case shows it may cause flares in patients with pre-existing chronic cutaneous lupus.
Area of Science:
- Oncology
- Dermatology
- Pharmacology
Background:
- 5-Fluorouracil (5-FU) is a widely used antineoplastic agent for various cancers.
- Cutaneous reactions are known side effects of 5-FU treatment.
- Chronic cutaneous lupus erythematosus (CCLE) is an autoimmune condition affecting the skin.
Observation:
- A patient with a history of CCLE developed a flare of their condition.
- The flare occurred after initiating systemic 5-FU therapy for breast cancer.
- The patient's lupus symptoms reappeared or worsened during 5-FU treatment.
Findings:
- Systemic administration of 5-FU can precipitate or exacerbate chronic cutaneous lupus.
- This suggests a potential drug-induced lupus-like reaction or a flare of pre-existing autoimmune disease.
- The antimetabolite nature of 5-FU may play a role in immune dysregulation.
Implications:
- Clinicians should be aware of the potential for 5-FU to trigger lupus flares in susceptible individuals.
- Monitoring for cutaneous lupus symptoms is crucial in patients with a history of lupus receiving 5-FU.
- Further research may elucidate the mechanisms behind 5-FU-induced lupus exacerbations.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
01:27Acne Infection
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
01:01Hypersensitivity Reactions: Cytolytic Reactions
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...